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Psychometric properties of the Fatigue Assessment
Scale (FAS) in women with breast problems1
Jolanda De Vries 2 (Tilburg University, The Netherlands),
Alida F. Van der Steeg (Emma Children’s Hospital, The Netherlands), and
Jan A. Roukema (Tilburg University, The Netherlands)
ABSTRACT. To examine the usefulness of the Fatigue Assessment Scale (FAS) in
women with benign breast problems (BBP) and women with early stage breast cancer
(BC). Women with a palpable lump in the breast or an abnormality on a screening
mammography (N = 560) completed the FAS (four time points) and measures of
anxiety, depressive symptoms, neuroticism, and fatigue. The FAS appeared to have
a good fit in the total population (Comparative Fit Index (CFI) = .96; ×2 (29) = 104.5;
p < .001; Nonnormed Fit Index (NNFI) = .95; Root Mean Square Error of Approximation
(RMSEA) = .091), the BC group (CFI = .95; X2 (32) = 69.6, p < .001; NNFI = .91;
RMSEA = .090), and the BBP group (CFI = .95; ×2 (34) = 99.9, p < .001; NNFI =
.92; RMSEA = .105). The internal consistency (.89 total group) and the test-retest
reliability (BBP group; r = .88 three months interval) were good. The FAS was a
distinct factor from depressive symptoms, neuroticism, and state anxiety. In conclusion,
the FAS has good reliability and validity in women with breast problems and measures
fatigue without substantial overlap with depressive symptoms, state anxiety, and
neuroticism.
KEY WORDS. Fatigue. Breast cancer. Benign breast problems. FAS. Instrumental
study.
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RESUMEN. Se examina la utilidad de la Escala de Evaluación de la Fatiga (FAS) en
mujeres con problemas benignos de mama (BBP) y en mujeres con cáncer precoz de
mama (BC). Las mujeres con un nódulo palpable en la mama o una anomalía en una
mamografía de cribado (N = 560) completaron la FAS (en cuatro momentos) y medidas
de ansiedad, síntomas depresivos, neuroticismo, y fatiga. La FAS tuvo un buen ajuste
en la población total (CFI = 0,96; ×2 (29) = 104,5, p < 0,001; NNFI = 0,95; RMSEA
= 0,091), en el grupo de BC (CFI = 0,95; X2 (32) = 69,6, p < 0,001; NNFI = 0,91;
RMSEA = 0,090) y en el grupo BBP (CFI = 0,95; ×2 (34) = 99,9, p < 0,001; NNFI
= 0,92; RMSEA = 0,105). La consistencia interna (0,89 para el grupo total) y la
fiabilidad test-retest (grupo BBP, r = 0,88 intervalo de tres meses) fueron buenas. La
FAS diferenció síntomas depresivos, neuroticismo, estado de ansiedad. En conclusión,
la FAS tiene una buena fiabilidad y validez en mujeres con problemas de mama y mide
fatiga sin superponerse de forma importante con síntomas depresivos, estado de
ansiedad y neuroticismo.
PALABRAS CLAVE. Fatiga. Cáncer de mama. Problemas benignos de mama. FAS.
Estudio instrumental.
Fatigue is a major problem in cancer patients. A cause is cancer therapy, but fatigue
can remain a problem long after the ending of treatment (De Jong, Courtens, Abu-Saad,
and Schouten, 2002; Jean-Pierre et al., 2007; Jereczek-Fossa, Marsiglia, and Orecchia,
2002). Like chronic fatigue in general, this cancer-related fatigue (CRF) is characterized
by the subjective and persistent feeling of tiredness that is not resolved by rest or sleep
and is disproportional compared with patients’ activity level (Jean-Pierre et al., 2007).
The specific component of CRF is its cause, namely cancer (e.g., treatment and disease
process). Given its subjectivity, fatigue is mainly measured with self-report questionnaires.
Recently, the questionnaires that have been used for measuring CRF have been reviewed
(Jean-Pierre et al., 2007). These questionnaires could be divided into unidimensional
and multidimensional measures, cancer-specific or generic fatigue measures, and fatigue
measures and fatigue subscales of questionnaires assessing other concepts. The use
of generic fatigue measures was considered a disadvantage. Disease-specific measures
have the important advantage that they are tailored for use in a cancer population.
Hence, they are expected to have higher test-retest reliability and sensitivity to change.
However, they have the obvious disadvantage of being less useful in benign patients
or healthy persons.
Apart from fatigue, cancer patients often suffer from depressive symptoms and
anxiety (Akechi, Okuyama, Imoto, Yamawaki, and Uchitomi, 2001; Hall, A’Hern, and
Fallowfield, 1999; Woods and Williams, 2002). Fatigue is related to depression and
anxiety (Servaes, Van der Werf, Prins, Verhagen, and Bleijenberg, 2001). Fatigue is even
a classic symptom of depression. In addition, fatigue is an aspect of the personality
characteristic neuroticism (Costa and McCrae, 1989). Therefore, assessing fatigue without
substantial overlap with related concepts, such as depression, is perceived as an
important challenge (Jean-Pierre et al., 2007).
The Fatigue Assessment Scale (FAS) (Michielsen, De Vries, and Van Heck, 2003),
a generic 10-item questionnaire, has been shown to measure fatigue independently from
Int J Clin Health Psychol, Vol. 10. Nº 1
DE VRIES et al. Psychomotric properties of the Fatigue Assessment Scale (FAS) 127
depression and neuroticism (De Vries, Michielsen, Van Heck, and Drent, 2004; Michielsen
et al., 2003). In a recent review on fatigue scales in stroke patients, the FAS was
considered the best option for assessing fatigue in stroke patients (Mead et al., 2007).
The major aim of this instrumental study (Montero and León, 2007; Ramos-Álvarez,
Moreno-Fernández, Valdés-Conroy, and Catena, 2008) was to examine the usefulness of
the FAS to measure fatigue in women with early stage breast cancer (BC group) and
benign breast problems (BBP group). The internal consistency, test-retest reliability,
sensitivity to change, and construct validity (convergent and divergent) were predicted
to be good. Concerning divergent validity, the FAS was expected to assess fatigue
distinct from depressive symptoms, state anxiety, and neuroticism. We included the BC
and the BBP group in order to show that the FAS has equally good psychometric
properties in both women who after baseline measurement appeared to have breast
cancer and those who appeared to have a benign breast problem.
Method
Sample
Women visiting the outpatient clinics of the St. Elisabeth Hospital Tilburg (September
2002 and February 2007), the Maasland Hospital Sittard (August 2004-December 2005),
or the Jeroen Bosch Hospital Den Bosch (January 2006-February 2007), the Netherlands,
with a palpable lump in the breast or an abnormality on a screening mammography were
asked to participate in a prospective follow-up study examining the role of personality
characteristics in patients’ quality of life scores after diagnosis and possible treatment.
The study concerned women with early stage breast cancer (BC group) and women with
a benign breast problem (BBP group). Therefore, women with advanced breast cancer
were not asked to participate. Women with previous breast problems in their medical
history were excluded from the study. When the women were asked to participate in the
study and completed the first set of questionnaires, it was unknown whether they had
breast cancer or a benign breast problem. Once diagnosis was known, diagnosis was
the reference point for subsequent measurement times for benign patients. For breast
cancer patients the reference point was surgical treatment, because otherwise follow-
up measures would interfere with timing of treatment modalities. From the patients who
were referred by their general practitioner to the Department of Surgery of one of the
participating hospitals and were eligible for participation in the study (N = 752), 560
(74.5%) agreed to participate. The most important reasons for not participating were the
length of the questionnaires and the amount of stress the women experienced which
they felt compromised concentration while completing the questionnaires. Four patients
were excluded from the study because they had a locally advanced carcinoma or proven
systemic disease. In addition, a number of women did not fully or correctly complete
the questionnaires. All participants gave written informed consent.
Instruments
– The FAS (Michielsen et al., 2003) is a fatigue questionnaire consisting of 10
items. Five questions of the FAS reflect physical fatigue and five assess mental
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fatigue. Although these two aspects of fatigue are represented in the questionnaire,
the FAS has shown to be unidimensional in various populations (Michielsen et
al., 2003; Michielsen, De Vries, Van Heck, Van de Vijver, and Sijtsma, 2004), as
well as in sarcoidosis patients (De Vries et al., 2004; Michielsen, De Vries, Drent,
and Peros-Golubicic, 2005). The unidimensional structure indicates that the FAS
total score should be used. The response scale is a 5-point scale (1, never to
5, always). Scores on the FAS range from 10 to 50. The Cronbach alpha of the
FAS in a random sample of the Dutch working population was .90 and in a
sarcoidosis population .89. In addition, the FAS had the highest factor loading
in a factor analysis incorporating five fatigue questionnaires (De Vries, Michielsen,
and Van Heck, 2003; Michielsen et al., 2003). Correlations between the FAS and
the Beck Depression Inventory were .59 (De Vries et al., 2004 and between the
FAS and the CES-D .65 (Michielsen et al., 2003).
– The World Health Organization Quality of Life assessment instrument (WHOQOL-
100; WHOQOL group, 1995; Dutch version De Vries and Van Heck, 1995) consists
of 100 items that are divided in 24 facets covering six domains (Physical health,
Psychological health, Level of independence, Social relationships, Environment,
and Spirituality / Religion / Personal beliefs) and an overall QoL and general
health facet. The reliability and validity are satisfactory (De Vries and Van Heck,
1997; WHOQOL group, 1998), also in breast cancer (Den Oudsten, Van Heck, Van
der Steeg, Roukema, and De Vries, 2009), and the sensitivity to change is good
(Bonomi, Patrick, Bushnell, and Martin, 2000; O’Carroll, Smith, Couston, Cossar,
and Hayes, 2000). Each facet consists of four questions with 5-point Likert type
response scales. In the present study, only the facet Energy and Fatigue, a
unidimensional fatigue scale, was employed. A higher score indicates less fati-
gue. In a population consisting of persons with the chronic fatigue syndrome
and healthy persons, Cronbach’s alpha of the facet Energy and Fatigue was .95
and the correlation with the POMS scale Fatigue was -.85 (De Vries and Van
Heck, 1997). Thus, this facet has good validity and reliability.
– The Center for Epidemiological Studies-Depression Scale (CES-D) (Radloff, 1977)
is a 20-item scale designed to measure the presence and degree of depressive
symptoms. It has a 4-point response scale. For the Dutch population, reliability
and criterion validity appeared to be good (Beekman et al., 1997). For instance,
the internal consistency was .87 (Penninx et al., 2001). Furthermore, the sensitivity
was 100% and the specificity 88% (Beekman et al., 1997).
– The State-Trait Anxiety Inventory (STAI, Dutch version Van der Ploeg, Defares,
and Spielberger, 1980) consists of two scales, each containing 20 items, with a
4-point response scale (1, not at all to 4, very). It is a widely used measure with
good reliability and validity (Spielberger, Gorsuch, and Lushene, 1970; Van der
Ploeg et al., 1980). In the present study, only the state scale was employed. Test-
retest correlations were .86 for women with a 1 ½ hour time interval. Cronbach
alphas ranged between .87 and .91 and in a stress test, scores on state anxiety
increased (Van der Ploeg et al., 1980).
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– The Neuroticism-Extraversion-Openness Five Factor Inventory (NEO-FFI; Costa
and McCrae, 1989; Dutch version Hoekstra, Ormel, and De Fruyt, 1996) is
developed to study an individual’s personality. The following five personality
factors are tested: neuroticism, extraversion, openness, agreeableness and
conscientiousness. The questionnaire consists of 60 items with a 5-point response
scale (1, totally disagree to 5, totally agree). The psychometric properties are
good (Costa and McCrae, 1989, Hoekstra et al., 1996). In the present study only
the factor neuroticism was used. This factor assesses six aspects belonging to
neuroticism, including fatigue. The Cronbach alpha’s of this factor ranged from
.82 to .88. Test-retest correlations were .80 and .82. Furthermore, this factor
correlated .62 with the state anxiety scale of the STAI and .68 with the total score
of the CES-D (Hoekstra et al., 1996).
Medical information, e.g., diagnosis and adjuvant treatment, were obtained from the
medical records of the patients.
Procedure
All women completed the questionnaires four times: before diagnosis (T1) and one
(T2), three (T3), and six (T4) months after diagnosis (benign patients) or surgical
treatment (breast cancer patients). This means that T1 was one month after diagnosis
for the benign patients and one month after surgery for the breast cancer patients.
Subsequently, T3 and T4 were three and six months after diagnosis for the benign group
and after surgical treatment for the breast cancer group. Questionnaires were completed
at home or in the hospital, prior to their check up/visit.
Statistical procedure
Confirmatory factor analysis (AMOS 4.0) (Arbuckle, 1999), method maximum likelihood,
was used to test the structure of the FAS in the total group as well as both subgroups
(BC and BBP). The estimation method used was maximum likelihood. The internal
consistency was calculated using Cronbach’s alpha coefficients for the total group and
both subgroups. A value of .70 or higher is being considered as evidence of good
reliability (Nunnally, 1978). Test-retest reliability was examined in the BBP group by
calculating Pearson correlations between T2 and T3 and between T3 and T4. To provide
information on convergent validity, Pearson correlations were calculated for the total
group and the two subgroups between the FAS and the facet Energy and Fatigue of
the WHOQOL-100. To examine the divergent validity of the FAS, factor analyses (prin-
cipal axis factoring; varimax rotation) were conducted concerning a) fatigue and depressive
symptoms, b) fatigue and neuroticism, and c) fatigue and state anxiety. In each factor
analysis, a forced two-factor solution was used, because each time two distinct constructs
were expected (criterion for a significant factor loading > .30). The Kaiser-Meyer-Olkin
(KMO) measure of sampling adequacy was examined. A KMO of .50 or lower is considered
barely acceptable, a value between .50- .70 is mediocre, between .70- .80 is good,
between .80- .90 is great, and a KMO of .90 or higher is considered superb (Field, 2005).
Finally, analysis of variance (ANOVA) for repeated measures was used to examine
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scores on the FAS across time in both patient subgroups. If the subgroups were
different with regard to one or more demographic characteristics, these aspects were
included in the ANOVA as covariates. If indicated, independent sample t-tests and
paired t-tests were used to examine differences between subgroups at one time point
and differences between two measurement times, respectively. Except for the confirmatory
factor analyses, all analyses were done with SPSS for Windows (version 14).
Results
Demographic characteristics of the participants are shown in Table 1. In the group
of women suspected of having breast cancer (N = 560), 204 appeared to have early stage
breast cancer (BC group) and 356 appeared to have a benign breast problem (BBP
group) after T1. Women in the BC group appeared to have scored higher on state
anxiety at T1 compared with women in the BBP group (t(461) = -6.637; p < .001). Women
who participated in the study were younger (t(546) = 2.96; p = .003) than the non-
participants. Across time, a number of patients dropped out of the study. In the BBP
group, the drop out percentage was 44.1 and was significantly higher compared with
the BC group (drop out 27.7%; Chi-square(1) = 13.52; p < .001). Apart from this
difference, the patients who dropped out of the study did not differ from the patients
who remained in the study with regard to having children, having paid work, educational
level, marital status, age and fatigue scores at the various time points.
TABLE 1. Patient characteristics of the study participants.
Note. For age and the psychological factors mean±sd are presented. * p < .05; # p < .005;
FAS=Fatigue Assessment Scale; WHOQOL-100=World Health Organization Quality of Life assessment
instrument-100.
Internal structure
Subsequently, the structure of the FAS was tested with a confirmatory factor
analysis. In the total group, the model without allowing for any correlated error terms




BC group  
(n=204) 
Demographic factors    
Age: mean (SD) 54.9 (10.5) 52.7 (10.5) 58.7 (9.2) 
Living with a partner#: yes/no/missing 78.6/18.2/3.2 80.3/16.9/2.8 75.5/20.6/3.9 
Children: yes/no/missing 83.2/13.8/3.0 82.6/14.3/3.1 84.3/12.7/3.0 
Educational level#:   
low / middle / high/missing 
33.8/42.9/18.6/4.7 31.5/43.3/20.2/5.0 37.7/42.2/15.7
/4.4 
Paid work#: yes/no/missing 45.7/52.1/2.2 51.4/46.3/2.3 36.3/61.8/1.9 
Psychological factors    
Fatigue (FAS) 20.5 (7.2) 21.0 (7.2) 19.7 (7.0) 
Fatigue (WHOQOL-100) 14.3 (3.4) 14.0 (3.5) 14.8 (3.3) 
Depressive symptoms 10.7 (8.4) 10.7 (8.8) 10.5 (7.7) 
Neuroticism 30.8 (7.1) 31.2 (7.0) 30.2 (7.1) 
State anxiety# 42.8 (14.0) 39.8 (13.1) 48.2 (14.1) 
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had a Comparative Fit Index (CFI) of .93 (Nonnormed Fit Index (NNFI) = .92; Root Mean
Square Error of Approximation (RMSEA) = .110). To reach a better fit, the model required
six correlations of two error terms (‘bothered by fatigue’ with ‘tired quickly’; ‘don’t do
much’ with ‘problems starting things’; ‘don’t do much’ with ‘mentally exhausted’;
‘problems starting things’ with ‘problems thinking clearly’; ‘problems starting things’
with ‘no desire to do anything’; ‘no desire to do anything’ with ‘mentally exhausted’)
to reach a CFI of .96 (χ2(29) = 104.5, p < .001; NNFI = .95; RMSEA = .091) (see Figure
1). Within the BC group, the CFI of the basic model was only .77. However, the CFI
could be increased to .95 (χ2(32) = 69.6, p < .001; NNFI = .91; RMSEA = .090) by adding
three correlations between error terms (‘bothered by fatigue’ with ‘tired quickly’; ‘problems
starting things’ with ‘problems thinking clearly’ and ‘problems starting things’ with ‘no
desire to do anything’). The CFI of the basic model in the BBP group was .84. This could
be increased to .95 by adding one correlation between the error terms of the questions
‘bothered by fatigue’ and ‘tired quickly’ (χ2(34) = 99.9, p < .001; NNFI = .92; RMSEA =
.105). Any additional correlation between error terms did not result in a better fit.
Reliability
The internal consistency (Cronbach’s alpha) of the FAS for the total group was .89.
For the BC and BBP groups separately, the alphas were .88 and .90, respectively. The
test-retest correlations, examined in the BBP group, between T2 and T3 (two months
interval) was .87 (p < .001) and between T3 and T4 (three months interval) the correlation
was .88 (p < .001).
Validity
In the total group, the correlation with the WHOQOL-100 facet Energy and Fatigue
was -.70 (p < .001). In the subgroups the correlations was the approximately the same
(r = -.67, p < .001 for BBP group and r = -.74, p < .001 for BC group). After removing
the overlap in items between the FAS and the WHOQOL-100 facet Energy and Fatigue
(2 items), the correlations between both scales remained practically the same (total r =
-.69; BBP group r = -.66; BC group r = -.73, all p’s < .001).
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TABLE 2. Factor loadings of the fatigue (FAS) and depressive symptoms




Sad .75  
Depressed  .72 - 
Could not shake off the blues  .72 - 
Fearful .66 - 
Crying spells  .66 - 
Trouble keeping my mind on what I was doing  .64 - 
Sleep was restless  .57 - 
Appetite was poor  .55 - 
Everything I did was an effort .55 .49 
Enjoyed life -.52 - 
Happy                       -.51 - 
Lonely .49 - 
Talked less .48 - 
Bothered by things  .47 - 
Can concentrate quite well Q10 - - 
Hopeful about the future     - - 
Life a failure - - 
Just as good as other people - - 
Tired very quickly Q2 - .85 
Bothered by fatigue Q1    - .80 
Physically exhausted Q5 - .79 
Don't do much during the day Q3 - .70 
Problems to start things Q6 - .65 
Mentally exhausted Q9 .49 .60 
No desire to do anything Q8 .42 .60 
Enough energy for everyday life Q4 - -.52 
Problems to think clearly Q7 .42 .50 
Could not get 'going'    .49 .49 
People disliked me - - 
People were unfriendly - - 
Note. Indicates no factor loading higher than .39. Items in italics are FAS-items. The regular font
style is used for the Center for Epidemiological Studies-Depression Scale items.
A factor analysis on the FAS-items and the CES-D items with a forced two-factor
solution, showed clear factors, Fatigue and Depressive symptoms (KMO = .92). Two
depressive symptom items had cross-loadings on the fatigue dimension (see Table 2).
These items (everything I did was an effort, could not get ‘going’) concerned the CES-
D subscale Somatic Retarded Activity and had a similar or only slightly higher factor
loading on the Depressive symptoms factor than on Fatigue factor. Three FAS items
(problems to think clearly, no desire to do anything, mentally exhausted) had cross-
loadings on the CES-D dimension. A factor analysis on the FAS-items and the Neuroticism-
items again showed clear factors (KMO = .90). The two factors found were Fatigue and
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Neuroticism (see Table 3), without any substantial cross-loadings. The factor analysis
on the items from the anxiety and fatigue scales showed a clear state anxiety and a clear
fatigue dimension (KMO = .95; see Table 4). No substantial cross-loadings existed.
TABLE 3. Factor loadings of the fatigue (FAS) and the neuroticism (NEO-FFI) items
in a two-factor solution.
Note. Mean scores no factor loading higher than .40. Items in italics are FAS-items. The regular
font style is used for the Neuroticism-Extraversion-Openness Five Factor Inventory items.
Items Neuroticism Fatigue 
Often tense and nervous .65 - 
Seldom sad or depressed -.58 - 
Feel less .57 - 
Big strain .57 - 
Seldom anxious or worried -.53 - 
Feel completely useless .50 - 
When things go wrong, often discouraged and want to give up .49 - 
Often helpless .49 - 
Seldom lonely or sad -.47 - 
Not a worrier -.46 - 
Feel ashamed - - 
Often angry about how I am treated - - 
Physically exhausted Q5 - .80 
Tired very quickly Q2 - .79 
Bothered by fatigue Q1 - .75 
Mentally exhausted Q9 - .72 
Problems to start things Q6 - .72 
Don't do much during the day Q3 - .70 
No desire to do anything Q8 - .69 
Problems to think clearly Q7 - .59 
Enough energy for everyday life Q4 - -.51 
Can concentrate quite well Q10 - - 
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TABLE 4. Factor loadings of the fatigue (FAS) and the state anxiety (STAI) items in
a two-factor solution.
Items State anxiety Fatigue 
Am nervous .83 - 
Feel comfortable -.82 - 
Am jittery .82 - 
Am relaxed -.80 - 
Feel restless .79 - 
Am frightened .79 - 
Feel calm -.78 - 
Feel steady -.76 - 
Am worried .75 - 
Feel pleasant -.75 - 
Worry over misfortunes .74 - 
Feel satisfied -.73 - 
Feel content (item 8) -.71 - 
Am tense .70 - 
Feel hunted .69 - 
Feel self-confident -.69 - 
Feel secure -.66 - 
Feel confused .56 - 
Feel indecisive .48 - 
Feel at ease - - 
Tired very quickly Q2 - .82 
Physically exhausted Q5 - .80 
Bothered by fatigue Q1 - .78 
Problems to start things Q6 - .72 
Don't do much during the day Q3 - .71 
Mentally exhausted Q9 - .70 
No desire to do anything Q8  - .66 
Problems to think clearly Q7 - .58 
Enough energy for everyday life Q4 - -.53 
Can concentrate quite well Q10 - - 
Note. Mean scores no factor loading higher than .40. Items in italics are FAS-items. The regular
font style is used for the state anxiety items of the State-Trait Anxiety Inventory.
FAS scores across time
The ANOVA for repeated measures showed that fatigue scores changed over time
(F(2.679) = 5.43, p = .001; partial eta squared = .06; observed power = .93). This fatigue
score pattern between the two groups were different across time (F(2.679) = 14.36, p <
.001; partial eta squared = .153; observed power = 1.00). At T1, fatigue scores in the
BBP group were slightly higher than in the BC group and subsequently decreased. From
T2 onwards, the BC group scored higher on fatigue (see Figure 1).
Int J Clin Health Psychol, Vol. 10. Nº 1
DE VRIES et al. Psychomotric properties of the Fatigue Assessment Scale (FAS) 135
FIGURE 1. Fatigue scores of the BBP and BC group across time.
Discussion
The aim of this study was to examine the usefulness of the FAS for measuring
fatigue in women with early stage breast cancer (BC group) and benign breast problem
(BBP group). Results showed that the internal consistency of the FAS was good and
there is strong evidence for the unidimensional structure of the FAS. We have shown
that the FAS has good test-retest reliability in BC and BBP patients and demonstrated
signficant change in fatigue levels over time in both the BC and BBP groups, and pre-
/post-surgery in the BC group. Furthermore, the validity of the FAS was also good.
These findings are in accordance with the results from earlier studies among other types
of populations (De Vries et al., 2003; De Vries et al., 2004; Michielsen et al., 2003). In
these previous studies, the reliability of the FAS appeared to be good in a sample
representative for the general Dutch population, a working population, and sarcoidosis
patients and these studies also supported a unidimensional conceptualization of fatigue.
In the present article, these claims also hold for the BC and BBP groups. In addition,
it could be demonstrated that the validity of the FAS was also good. Recently, Jean-
Pierre et al. (2007) called assessing fatigue without a substantial overlap with related
concepts a challenge. We have shown that there is a significant amount of variance in
FAS scores beyond that explained by depressive symptoms, neuroticism, and state
anxiety. This suggests that the FAS indeed assess fatigue without a substantial overlap
with these other constructs.
The relationship between depressive symptoms and fatigue has often been found,
because fatigue is one of the symptoms of depression. However, in the present study
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items of the CES-D and the FAS loaded on two different factors as in the development
phase of the FAS (Michielsen et al., 2003). Only two depressive symptoms items
appeared to have substantial factor loadings (> .40) on the Fatigue factor, but these
cross-loadings were as high or lower than the loadings on the primary factor. A triplet
of FAS items had cross-loadings on the Depressive symptoms factor, although the
loadings on the Fatigue factor were clearly higher. The present finding that fatigue and
depressive symptoms are distinct concepts is in line with a study on breast cancer
survivors (Bower, Ganz, Aziz, and Fahey, 2002). They found that fatigue was not
secondary to depression, but co-occurred with depression as part of a coordinated
response elicited by cytokine actions of the central nervous system.
No substantial cross-loadings were found between the FAS and two other related
concepts, e.g., neuroticism (NEO-FFI) and state anxiety (STAI). Concerning neuroticism
this is particularly important because energy/fatigue is one of the six facets of neuroticism.
Apparently, the FAS does not tap into fatigue as part of personality.
In all three factor analyses, question 10 of the FAS (Can concentrate quite well)
either had a substantial cross-loading (depressive symptoms) or had a factor loading
< .40. In previous studies this FAS-item had the lowest factor loading of the all items
(Michielsen et al., 2004) and had a substantial cross-loading on a depressive symptom
factor (De Vries et al., 2004). Therefore, we suggest to remove question 10, resulting
in a 9-item questionnaire, when using the FAS in breast cancer patients. However, when
a researcher explicitly wants to include an item on concentration, question 10 can be
used.
A limitation of the present study is the dropout rate. This is especially relevant with
regard to the analyses across time. The dropout rate was higher in the BBP group. The
patients who did not remain in the study differed from the patients who remained in the
study with regard to age. Younger patients, more often in the BBP group, more frequently
dropped out of the study. The main reason for dropout in the BBP group was that
patients no longer wanted to be confronted with their visits to the hospital. In the BC
group stress was the main reason for dropping out of the study. Fortunately, participants
who left the study did not differ with regard to fatigue, depressive symptoms, neuroticism,
and state anxiety from those who completed all questionnaires. Another limitation is the
lack of several additional fatigue measures to further examine the construct validity of
the FAS. Only one other fatigue measure, the facet Energy and Fatigue of the WHOQOL-
100, was used in addition to the FAS. In previous studies, several other fatigue
questionnaires were employed in addition to the FAS and each time the FAS appeared
the best fatigue measure (De Vries et al., 2003; Mead et al., 2007). In addition, the FAS
is shown to assess fatigue apart from related concepts, a feature that other fatigue
measures used in cancer populations has not shown to posses. Future studies should
compare the usefulness of the FAS with other fatigue measures among BC and BBP
patients. A previous case-study showed that the FAS was capable of detecting change
in a sarcoidosis patient (Hoitsma et al., 2006).
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In conclusion, the FAS is unidimensional and has good psychometric qualities in
women with breast cancer and benign breast problems. Importantly, we have shown that
the FAS assess fatigue distinctly from the related concepts depressive symptoms,
neuroticism, and state anxiety. Given these psychometric properties, its shortness, and
ease of administration, it is a valuable tool for assessing fatigue in BC and BBP groups.
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